TRADING UPDATES: Avingtrans HS2 win; Metals Exploration's Runruno blow
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
Price | 15.50p on 29-08-2025 | at 09:15:14
---|---|
Change | 0.75p 5.08% |
Buy | 16.00p |
Sell | 15.00p |
Last Trade: | Buy 10,000.00 at 15.68p |
Day's Volume: | 80,638 |
Last Close: | 14.75p |
Open: | 14.75p |
ISIN: | GB00BDQZGK16 |
Day's Range | 14.75p - 15.50p |
52wk Range: | 2.90p - 18.15p |
Market Capitalisation: | £17.62m |
VWAP: | 15.4305p |
Shares in Issue: | 113.66m |
Sector: Health Care and Related Services
Listed In: FTSE AIM All-Share,
Fusion Antibodies (FAB) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 10,000 | 15.68p | Ordinary |
10:15:07 - 29-Aug-25 |
Buy* | 6,352 | 15.68p | Ordinary |
10:13:22 - 29-Aug-25 |
Buy* | 31,585 | 15.80p | Ordinary |
09:29:54 - 29-Aug-25 |
Buy* | 3 | 15.88p | Ordinary |
09:08:09 - 29-Aug-25 |
Buy* | 799 | 16.00p | SI Trade |
08:55:37 - 29-Aug-25 |
Buy* | 4 | 15.50p | Ordinary |
08:49:47 - 29-Aug-25 |
Sell* | 429 | 14.683p | Ordinary |
08:47:18 - 29-Aug-25 |
Buy* | 4 | 15.20p | Ordinary |
08:42:34 - 29-Aug-25 |
Buy* | 4 | 15.20p | Ordinary |
08:28:42 - 29-Aug-25 |
Buy* | 4 | 15.20p | Ordinary |
08:14:15 - 29-Aug-25 |
Fusion Antibodies (FAB) Regulatory News |
||
Date | Source | Headline |
---|---|---|
28th Aug 2025 7:00 am | RNS | Contract Win |
27th Aug 2025 7:00 am | RNS | Contract wins with existing client |
26th Aug 2025 7:00 am | RNS-R | Investor presentations |
5th Aug 2025 7:00 am | RNS | Grant of U.S. Patent for OptiMAL |
24th Jul 2025 10:56 am | RNS | Issue Notification: US Patent Update |
11th Jul 2025 7:00 am | RNS | Director/PDMR Shareholding |
2nd Jun 2025 7:00 am | RNS | Total Voting Rights |
22nd May 2025 2:33 pm | RNS | Update on U.S. Patent for OptiMAL® |
8th May 2025 7:00 am | RNS-R | Investor presentation |
7th May 2025 7:00 am | RNS | Issue of shares to non-executive directors |